SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 82 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $519,000 | +5.5% | 14,800 | 0.0% | 0.01% | -14.3% |
Q4 2018 | $492,000 | -34.0% | 14,800 | 0.0% | 0.01% | 0.0% |
Q3 2018 | $745,000 | -15.9% | 14,800 | 0.0% | 0.01% | -22.2% |
Q2 2018 | $886,000 | +30.7% | 14,800 | 0.0% | 0.01% | +28.6% |
Q1 2018 | $678,000 | +9.7% | 14,800 | -4.5% | 0.01% | 0.0% |
Q4 2017 | $618,000 | 0.0% | 15,500 | +0.3% | 0.01% | 0.0% |
Q3 2017 | $618,000 | -15.5% | 15,450 | -8.8% | 0.01% | -22.2% |
Q2 2017 | $731,000 | +38.2% | 16,950 | +0.3% | 0.01% | +50.0% |
Q1 2017 | $529,000 | +88.9% | 16,900 | +52.3% | 0.01% | +50.0% |
Q4 2016 | $280,000 | -53.7% | 11,100 | -77.8% | 0.00% | -66.7% |
Q1 2015 | $605,000 | +45.8% | 50,000 | 0.0% | 0.01% | +33.3% |
Q4 2014 | $415,000 | -5.5% | 50,000 | -1.1% | 0.01% | -18.2% |
Q3 2014 | $439,000 | -19.9% | 50,550 | +1.1% | 0.01% | -21.4% |
Q2 2014 | $548,000 | +22.6% | 50,000 | 0.0% | 0.01% | +7.7% |
Q1 2014 | $447,000 | +18.6% | 50,000 | 0.0% | 0.01% | +18.2% |
Q4 2013 | $377,000 | +2.7% | 50,000 | 0.0% | 0.01% | -15.4% |
Q3 2013 | $367,000 | +14.0% | 50,000 | 0.0% | 0.01% | 0.0% |
Q2 2013 | $322,000 | – | 50,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
S&T BANK/PA | 215,578 | $5,943 | 1.15% |
Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |